期刊文献+

细胞穿透肽介导外源物质入胞转运研究进度 被引量:3

Progress in delivery of exogenous molecules mediated by cell-penetrating peptides into cells
下载PDF
导出
摘要 细胞穿透肽(cell-penetrating peptides,CPP)是一类能够携带外源物质进入细胞的多肽,因其结构和功能的独特性和实用性,近20年里在生物医学领域得到了长足的发展。目前CPP向体内和体外输送物质的方法逐渐成熟。在基础研究领域,已成为研究细胞内分子相互作用的有用工具;在应用方面,CPP药物已进入临床前、临床Ⅰ和Ⅱ期试验,在肿瘤、中枢神经系统疾病和心血管疾病的治疗中显示出明显优势。本文对CPP的发展历程、分类、入胞机制和应用等做一综述。 Cell-penetrating peptides(CPP) are a type of polypeptides that can serve as vehicles for the delivery of exogenous molecules into cells.Because of their unique structure and function,CPP research in biomedical field has been develop ing rapidly during the last 20 years.Nowadays,the methods of CPP-mediated delivery ex vivo and in vivo have gradually become mature.In the field of basic medical sciences,CPP provide a promising tool for the study of molecular interaction in cells.In the field of application study,several CPP drugs have been introduced to preclinical study,phase Ⅰ and Ⅱ clinical trials,and have shown some advantages in the treatment of some refractory diseases,such as cancers,central nervous system diseases,and cardiovascular diseases.In this article,the development process,examples of recent research,idea of classification,uptake mechanisms,and the therapeutic potential of CPP are reviewed.
出处 《国际药学研究杂志》 CAS 2012年第2期108-113,共6页 Journal of International Pharmaceutical Research
基金 教育部博士点基金项目(20090182120017) 国家自然科学基金项目(31072098)
关键词 细胞穿透肽 药物载体 跨膜转运 分类法 cell-penetrating peptides drug carrier membrane transport classification
  • 相关文献

参考文献22

  • 1Brasseur R,Divita G. Happy birthday cell penetrating peptides:already 20 years[J].Biochimica Et Biophysica Acta,2010,(12):2177-2181.
  • 2Frankel AD,Pabo CO. Cellular uptake of the tat protein from human immunodeficiency virus[J].Cell,1988,(06):1189-1193.doi:10.1016/0092-8674(88)90263-2.
  • 3Joliot A,Pernelle C,Deagostini-Bazin H. Antennapedia homeobox peptide regulates neural morphogenesis[J].Proceedings of the National Academy of Sciences(USA),1991,(05):1864-1868.
  • 4Vivès E,Brodin P,Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus[J].Journal of Biological Chemistry,1997,(25):16010-16017.
  • 5Morris MC,Vidal P,Chaloin L. A new peptide vector for efficient delivery of oligonucleotides into mammalian cells[J].Nucleic Acids Research,1997,(14):2730-2736.
  • 6Schwarze SR,Ho A,Vocero-Akbani A. In vivo protein transduction:delivery of a biologically active protein into the mouse[J].Science,1999,(5433):1569-1572.doi:10.1126/science.285.5433.1569.
  • 7Xiang L,Zhou R,Fu A. Targeted delivery of large fusion protein into hippocampal neurons by systemic administration[J].Journal of Drug Targeting,2011,(08):632-636.
  • 8Lindgren M,Langel U. Classes and prediction of cell-penetrating peptides[J].Methods in Molecular Biology,2011.3-19.
  • 9Pooga M,Langel U. Synthesis of cell-penetrating peptides for cargo delivery[J].Methods in Molecular Biology,2005.77-89.
  • 10Toivonen JM,Oliván S,Osta R. Tetanus toxin C-fragment:the courier and the cure[J].Toxicology,2010,(11):2622-2644.

二级参考文献29

  • 1Pardridge WM.Blood-brain barrier delivery of protein and non-viral gene therapeutics with molecular Trojan horses.J Control Release,2007,122:345-348.
  • 2Foust KD,Nurre E,Montgomery CL,et al.Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes.Nat Biotechnol,2009,27:59-65.
  • 3Ko YT,Bhattacharya R,Bickel U.Liposome encapsulated polyethylenimine/ODN polyplexes for brain targeting.J Control Release,2009,133:230-237.
  • 4Boado RJ.Blood-brain barrier transport of non-viral gene and RNAi therapeutics.Pharm Res,2007,24:1772-1787.
  • 5Zhang Y,Schlachetzki F,Zhang YF,et al.Normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental Parkinsonism with intravenous nonviral gene therapy and a brain-specific promoter.Hum Gene Ther,2004,15:339-350.
  • 6Huang R,Ke W,Liu Y,et al.The use of lactoferrin as a ligand for targeting the polyamidoamine-based gene delivery system to the brain.Biomaterials,2008,29:238-246.
  • 7Xia CF,Zhang Y,Zhang Y,et al.Intravenous siRNA of brain cancer with receptor targeting and avidin-biotin technology.Pharm Res,2007,24:2309-2316.
  • 8Vinogradov SV,Batrakova EV,Kabanov AV.Nanogels for oligonucleotide delivery to the brain.Bioconjug Chem,2004,15:50-60.
  • 9Kumar P,Wu H,McBride JL,et al.Transvascular delivery of small interfering RNA to the central nervous system.Nature,2007,448:39-43.
  • 10Miana-Mena FJ,Muoz MJ,Roux S,et al.A Non-viral vector for targeting gene therapy to motoneurons in the CNS.Neurodegenerative Dis,2004,1:101-108.

同被引文献64

  • 1张奇,项光亚,龙娜,林佳亮,曾凡波.叶酸靶向的PGA联合N-苯乙酰化阿霉素的抗肿瘤活性[J].药学学报,2005,40(11):1046-1050. 被引量:6
  • 2吕秋军.生物技术药物免疫原性的评价及面临的挑战[J].中国新药杂志,2007,16(3):181-188. 被引量:24
  • 3Patel L N, Zaro J L, Shen W C. Cell penetrating peptides., intracellular pathways and pharmaceutical perspectivesI-J3. Pharmaceutical Research, 2007, 24 (11) : 1977-1992.
  • 4Frankel A D, Pabo C O. Cellular uptake of the tat protein from human immunodefieieney virus~J]. Cell, 1988,55 (6) : 1189-1193.
  • 5Lundin P, Johansson H, Guterstam P, et al. Distinct uptake routes of cell-penetrating peptide conjugates EJ]. Bioconjugate Chemistry, 2008, 19 (12): 2535- 2542.
  • 6Drin G,Cottin S, Blanc E, et al. Studies on the inter- nalization mechanism of cationic cell-penetrating pep- tides[J]. Journal of Biological Chemistry, 2003,278 (33) .. 31192-31201.
  • 7Letoha T, Keller-Pint~r A, Kusz E, et al. Cell-pene- trating peptide exploited syndecans F J]. Biochim et Biophysica Acta, 2010,1798(12) : 2258-2265.
  • 8Subrizi A,Tuominen E, Bunker A, et al. Tat(48-60) peptide amino acid sequence is not unique in its cell penetrating properties and cell-surface glycosamino- glycans inhibit its cellular uptake[J]. Journal of Con- trolled Release, 2012,158(2) : 277-285.
  • 9Tiinnemann G, Martin R M, Haupt S, et al. Cargo- dependent mode of uptake and bioavailability of TAT- containing proteins and peptides in living cells EJ]. Faseb Journal,2006,20(11) : 1775-1784.
  • 10Rousselle C, Clair P, Lefauconnier J M, et al. New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vectormediated strategy[J]. Molecular Pharmacology, 2000, 57 (4) : 679-686.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部